ライフサイエンスコーパス: stay

1 (0.74% for office visits; 0.51% for hospital stays).

2 old, < 7 g/dL) of RBC transfusion during ICU stay.

3 pancreatitis, may reduce length of hospital stay.

4 bleeding, and length of intensive care unit stay.

5 ians except for a lower High Dependency Unit stay.

6 viewed models to predict adult ICU length of stay.

7 leading to a reduction in hospital length of stay.

8 ia, time of recovery, and length of hospital stay.

9 or delirium twice daily throughout their ICU stay.

10 , and a mean reduction of 1.5 days length of stay.

11 isk factor for mortality and longer hospital stay.

12 f prevention and any difference in length of stay.

13 ; all-cause ICU mortality; and length of ICU stay.

14 associated with increased hospital length of stay.

15 ventilation, ICU utilization, and length of stay.

16 no differences in ICU and hospital length of stay.

17 (the basal-bolus group) during the hospital stay.

18 associated with 1 additional long inpatient stay.

19 and shorter length of delirium/coma and ICU stay.

20 RIPC may also shorten MV duration and ICU stay.

21 $4719 (interquartile range $3124-$7209) per stay.

22 treatment associated with hospital length of stay.

23 ated with longer duration of MV and hospital stay.

24 ventilation, ICU utilization, and length of stay.

25 identifying hospital admissions with an ICU stay.

26 time to effective therapy and the length of stay.

27 ostoperative outcomes and greater lengths of stay.

28 is beneficial in reducing hospital length of stay.

29 icrobial stewardship, and length of hospital stay.

30 chanical ventilation, and length of hospital stay.

31 pital versus the hospital of their index ICU stay.

32 diate, and incremental care, to identify ICU stays.

33 targeted interventions could decrease these stays.

34 ger overall hospital and intensive care unit stays.

35 ted with shorter hospital and intensive care stays.

36 io [aOR], 1.97; P = .01) and longer hospital stay (1.34; P < .001).

37 l mortality was 33.2%, with median length of stay 11 days (interquartile range, 5-22), and median tot

38 51 vs 117 hours; P < .001), but not hospital stay (11 vs 12 days; P = .50), was longer in the 48-hour

39 ; P < .001) and prolonged length of hospital stay (12 vs 8 days; P = .04).

40 6.6% vs 21.0%; P = 0.22), length of hospital stay (12.2 vs 12.2; P = 0.99) and rate of stoma closure

41 s ratio 1.51, P = 0.002) and longer hospital stays (+12%, P = 0.006).

42 Throughout the ICU stay, 127 patients (36%) received high-flow nasal oxygen

43 The median length of intensive care unit stay (151 vs 117 hours; P < .001), but not hospital stay

44 .63; 95% CI, 1.01-2.63) and longer length of stay (2.25 d; CI, 0.58-3.92).

45 y were more likely to have a longer hospital stay (2.9 d vs. 2.5 d, P <0.001) and were more likely to

46 n with delirium (adjusted relative length of stay, 2.3; CI = 2.1-2.5; p < 0.001), as was duration of

47 on (odds ratio for log-transformed length of stay: 2.39 [99% confidence interval: 2.31 to 2.47]).

48 ry Medical Care Surveys) and 108472 hospital stays (2010 National Hospital Discharge Survey).

49 days), as was the median length of hospital stay (21 days vs. 33 days) (P<0.001 for both comparisons

50 ix [3.9%] patients; p = 0.77), ICU length of stay (24.7 +/- 22.9 and 23 +/- 23.8 d; p = 0.52), and mo

51 rquartile range, 2.5-5.0]; p = 0.03) and ICU stay (3.0 d [interquartile range, 2.0-4.0] vs 4.0 d [int

52 toperative healthcare utilization (length of stay, 30-d readmission, and discharge destination) and c

53 condary outcomes included hospital length of stay, 30-day major complication rates, discharge destina

54 brane oxygenation; p = 0.037) and longer ICU stay (32.5 [19.5-78] vs. 19 [10.5-27.5] days; p = 0.003)

55 ; 95% CI, 0.92-1.35; P = 0.27) and length of stay (-4% for nonoverlapping; 95% CI, -4% to -3%; P < 0.

56 2 vs. 6 days, P = 0.001), and total hospital stay (5 vs. 8 days, P = 0.001) were observed after lapar

57 lower adjusted intensive care unit length of stay (5.3 days [95% CI, 4.2-6.7] versus 9.19 days [95% C

58 mplications (6.6% vs 9.4%), median length of stay (6 days vs 6 days), readmission (1.9% vs 3.1%), and

59 , intensive care unit and hospital length of stay (6.0 versus 6.5 days, P<0.001), and combined 30-day

60 of ventilation, duration of ICU and hospital stay, 6-month recurrence, and rehospitalization rates.

61 2; P = 0.005) and required greater length of stay (7 versus 6 days; RR 1.15; 95% CI 1.1-1.19; P < 0.0

62 Participants attended four inpatient stays (72 h each, separated by at least 5 days), during

63 r the placebo group, P = .67), ICU length of stay (8 days for the ganciclovir group vs 8 days for the

64 percent (n = 333) died during their hospital stay, 8.1% (n = 222) of patients died postdischarge, and

65 nd discharge destination) and cost (hospital stay, 90-, 180-, and 365-d) after adjusting for number o

66 $24,263; P = 0.005), 12.4% longer length of stay (95% CI 2.3%-23.5%; adjusted means 5.9 vs 5.2 days;

67 ill decrease over the coming years, although staying above the long-term (1981-2010) average.

68 maining platelet units at the end of any day stays above 10 in our model during the same period.

69 The length of stay according to the application was positively correla

70 han half of all elderly patients with a CICU stay across the United States now have primary noncardia

71 CI, 2.27-3.22; P < .001) and longer hospital stay (adjusted multiplicative difference, 2.14; 95% CI,

72 imary outcome, durations of ICU and hospital stay, adverse events, and all-cause mortality at 30 days

73 We compared outcomes mortality and length of stay after adjustment for registry-predicted risk, case-

74 xchange value") to explain the likelihood of staying after controlling for life-course events.

75 venue center codes to correctly identify ICU stays among hospitalized patients.

76 Hospital length of stay and 1-year readmission with inflammatory skin condi

77 identifying unexpectedly long ICU length of stay and across ICUs for benchmarking, with low calibrat

78 eased morbidity including length of hospital stay and an increased incidence of resistant infections

79 Median length of stay and cost of readmissions were 4 days (interquartile

80 Increased length of stay and costs of care were associated with Asian race.

81 was also associated with a reduced length of stay and improved influenza detection and antiviral use,

82 Improvements in length of stay and in operative mortality among elderly patients s

83 her use of a CDSS reduces hospital length of stay and in-hospital mortality for patients with AKI.

84 Hospital length of stay and postoperative complication rates were also sign

85 ation with outcomes, including ICU length of stay and survival.

86 may both be associated with longer length of stay and worse outcome.

87 -assessed risk in the decision to migrate or stay and, equally important, confirm the role of the end

88 npatient Medicare Part B spending, length of stay, and 30-day readmissions.

89 k to reduce SSI, pneumonia, sepsis, hospital stay, and antibiotic use.

90 identifying unexpectedly long ICU length of stay, and benchmarking ICUs.

91 o examine risk factors, mortality, length of stay, and cost associated with admission to the ICU for

92 significant increase in mortality, length of stay, and cost.

93 In-hospital outcomes (mortality, length of stay, and discharge destination) and postdischarge outco

94 Advanced age, length of stay, and duration of life support were the least accept

95 ciated with reduced mortality, ICU length of stay, and duration of mechanical ventilation.

96 tilation, intensive care unit stay, hospital stay, and highest primary graft dysfunction score within

97 issed intra-abdominal injuries, ED length of stay, and hospital charges.

98 ion for AF, in-hospital mortality, length of stay, and hospital payments.

99 mechanical ventilation, intensive care unit stay, and inotrope use; and fewer electrolyte abnormalit

100 ose delay and increased mortality, length of stay, and mechanical ventilation requirement.

101 Duration of ventilation, intensive care unit stay, and mortality (6, 17, and 29% for the three groups

102 s, injury severity score, length of hospital stay, and number of mortalities.

103 pendicitis, postoperative length of hospital stay, and overall duration of postoperative antibiotic t

104 , intensive care unit and hospital length-of-stay, and rates of discharge to home.

105 nal abscess, reoperation, length of hospital stay, and readmission.

106 racteristics, cultured pathogens, lengths of stay, and short-term and long-term mortality.

107 ly fatal McCabe scores), prolonged length of stay, and the use of invasive medical devices.

108 lity, hospital length of stay, ICU length of stay, and ventilator-free days.

109 adverse event, prolonged hospital length of stay, and wound infection/dehiscence).

110 lization: emergency room visits and hospital stays, and (4) total annual and out-of-pocket healthcare

111 al infections, prolonged intensive care unit stays, and poor functional status at discharge (P < 0.05

112 -day, and 1-year mortality; longer length of stay; and several other important adverse outcomes.

113 s or brief courses of antibiotics, length of stay, antiviral use, isolation facility use, and safety.

114 was positively correlated with the length of stay ascertained via the electronic medical record (r=0.

115 s for instance) provide very low yields: QDs stay at the plasma membrane or are trapped in endosomes.

116 associated with greater overexploitation or staying at current options for longer than is optimal.

117 able challenges face health workers who have stayed behind, and with no health care a major factor in

118 that the risk of family 're-identification' stays below a pre-specified risk threshold.

119 in ICU and hospital mortality and length of stay between 1997 and 2013 despite little change in seve

120 re was no difference in the median length of stay between the 2 groups.

121 reased out-of-bed activities during hospital stay but did not improve outcomes.

122 t there was a mean decrease in ICU length of stay by 1.21 days (n = 3 studies; 95% CI, -2.25 to -0.16

123 6 days (95% CI, 1.0-2.3), and length of PICU stay by 2.1 days (95% CI, 1.3-3.0), as well as an increa

124 reduction in the adjusted hospital length of stay by 2.64 days (95% CI, 1.75-3.53 days; P < .001).

125 have resulted in shorter length of hospital stay by 30% to 50% and similar reductions in complicatio

126 d patient demographics, diagnoses, length of stay, circumstances, and outcome of admission.

127 atment and better outcomes than patients who stay close to home at low-volume centers.

128 lized and had significantly shorter hospital stays compared with infants born to unvaccinated mothers

129 ic data, hospital characteristics, length of stay, complications (surgical and systemic), and inpatie

130 tages of office visit conditions or hospital stay conditions seen were less than the applicable conco

131 included SSI incidence at 4 days, length of stay, cosmetic outcome, and patient satisfaction.

132 pneumonia, myocardial infarction, length of stay, cost, and mortality, and also a lower likelihood o

133 The median hospital stay declined over the years for both procedures (11 to

134 Risk-adjusted mean hospital stay decreased by 8.6%, representing nearly 10000 hospit

135 l mortality, 30-day mortality, and length of stay decreased during the study period.

136 ICU length of stay decreased from 6.5 to 5.8 days in the immediate pos

137 he same time period, mean hospital length of stay decreased; nontargeted conditions (10.4-8.4 days) a

138 s without ACS, the median length of hospital stays decreased by 2.9 hours (95% confidence interval, 2

139 edian, 98.5 hr; p = 0.003) and length of ICU stay (difference of median, 4.5 d; p = 0.006) were signi

140 ary outcomes were ICU and hospital length of stay, duration of mechanical ventilation, and frequency

141 Furthermore, length of stay during index hospitalization was directly associate

142 chanical ventilation and intensive care unit stay, electrolyte abnormalities and repletion doses, dur

143 ointly, whereas regions activated during the stay events clustered apart.

144 In the retrospective dataset, 102-of-215 ICU stays experienced >1 hypotension episode (median of 2.5

145 Reduced length-of-stay for inpatient surgical care requires the inclusion

146 The mean hospital stay for the moderate group was 12.4 days vs 10.9 days i

147 The mean ICU stay for the moderate group was 4.8 days vs 3.8 days for

148 tice during either office visits or hospital stays for each of 186 condition categories (eg, diabetes

149 l discharge rates and the length of hospital stay from cardiac arrest to discharge, stratified by use

150 significant difference in average length of stay, from 4.8 days +/- 7.0 to 4.2 days +/- 6.2 (P < .00

151 ansgenic plants and the corresponding longer stay-green phenotype is mainly due to increased chloroph

152 ncy, urology procedures, and with lengths of stay >30 days.

153 ensive care unit and its effect on length of stay has not been investigated.

154 er in-hospital mortality, hospital length of stay, hemorrhage requiring transfusion, and permanent pa

155 t genes rises before the onset of the night, stays high during the night, when mice normally ingest f

156 lity, 30-day readmission, hospital length of stay, hospital cost, and discharge disposition.

157 mechanical ventilation, intensive care unit stay, hospital stay, and highest primary graft dysfuncti

158 cluded 48-hour mortality, hospital length of stay, ICU length of stay, and ventilator-free days.

159 ntibiotic use, shortening length of hospital stay, improving influenza detection and treatment, and r

160 daily from admission until day 5 of the ICU stay in 30 critically ill patients (median [interquartil

161 eeding was associated with reduced length of stay in 4 of 7 studies (including 2 of 3 with low risk o

162 Importantly, when given the choice to stay in a habitat reflecting their acclimation temperatu

163 igration mechanism, where Ta atoms prefer to stay in clusters in the Cu matrix.

164 CVD risk increased with longer stay in Europe.

165 The length of stay in hospital was similar for both groups (median 4 d

166 Healthy volunteers and patients expected to stay in ICU for at least 3 days in whom enteral nutritio

167 osphate), to make a vital choice: whether to stay in one place and form a biofilm, or to leave it in

168 gh GIST displacement penalty was observed to stay in place.

169 sis that risk aversion extends the length of stay in the dwelling and, by extension, in the local lab

170 especified secondary outcomes were length of stay in the ICU and hospital, incidence of barotrauma, a

171 utcome was all-cause mortality and length of stay in the intensive care unit.

172 third case in an unvaccinated child who had stayed in the region during the week prior to disease on

173 conclude that the percentage of people ever staying in nursing homes is substantially higher than pr

174 e find that Caenorhabditis elegans sperm DNA stays in a fixed position at the opposite end of the emb

175 isk patients, discussions regarding extended stays in the intensive care unit, prolonged ventilator m

176 e (LF) is associated with prolonged hospital stay, increased cost and substantial mortality.

177 rgery and is associated with longer hospital stays, increased hospital costs, and 1-year mortality.

178 erences in duration of bacteremia, length-of-stay, infection-related length-of-stay, or readmission w

179 CD stayed inpatient for 5-7 days prior to the scans to stan

180 xpected to experience negative selection and stay intact under pressure of incessant mutation.

181 While the frameworks stay intact with the inclusion of Ar atoms, the permeabi

182 ealth-care service contact such as inpatient stay, intensive care, and psychosocial assessment.

183 issions within 30 days, (iii) long length of stay, (iv) healthcare acquired infections, and (v) estab

184 death within 72 hours of ICU discharge, ICU stay less than 24 hours, and end-stage renal disease.

185 e increasingly motivated to reduce length of stay (LOS) after lung cancer surgery, yet it is unclear

186 ative morbidity, and postoperative length of stay (LOS) among patients undergoing abdominal surgery.

187 itional variables predict length of hospital stay (LOS) in patients receiving ERAS protocols and conv

188 In-hospital mortality or ICU length of stay (LOS) of 3 days or more was a composite secondary o

189 ) admission, and hospital and ICU lengths of stay (LOS) were outcome measures for severity.

190 with longer kidney transplant (KT) length of stay (LOS), and modifies the association between LOS and

191 iagnoses, vital sign measurements, length of stay (LOS), hospital readmissions, and mortality.

192 d the secondary outcome was median length of stay (LOS).

193 < 0.001), and the overall hospital length of stay (LOS; 15.03 versus 9.02 days; P = 0.021).

194 een BMI and CAP outcomes (hospital length of stay [LOS], intensive care unit [ICU] admission, and inv

195 strategies, which contains the classical Win-Stay Lose-Shift rule as a special case.

196 low this threshold had shorter ICU length of stay, lower incidence of acute kidney injury, acute resp

197 Group 4 had shorter donor ICU stay, lower rate of moderate-to-severe graft macrosteato

198 es of potentially avoidable admissions (SICU stay </=24 hours, airway concerns, and somnolence) and d

199 S >/= 3), death within 72 hours, or hospital stay <48 hours were excluded.

200 sis (RR = 0.09; 95% CI, 0.01-0.94), hospital stay (mean = 9.66 days, 95% CI, 7.60-11.72), and duratio

201 urs; 95% CI, -21 to 2; P=0.09), and hospital stay (median, 14 days and 14 days, respectively; median

202 hout cancer had longer medical ICU length of stay (median, 5 vs 4 d; p = 0.0495), used mechanical ven

203 nce, -2 hours; 95% CI, -5 to 1; P=0.48), ICU stay (median, 72 hours and 84 hours, respectively; media

204 e patients also experienced reduced hospital stay (median: 8 days vs 9 days, P = 0.001).

205 de >/=3, 23.05% vs 23.7%; P > .99), hospital stay (median: 8 vs 8.5 days; P = .31), 30-day readmissio

206 re, including use of resources; ED length of stay; missed intra-abdominal injuries; or hospital charg

207 " without any detectable change in length-of-stay, morbidity or mortality.

208 2,710 adult patient stays with ICU length of stay more than 24 hours, of which 74,771 were ordered en

209 8 weeks (150.56 [73.11 to 310.06]), hospital stay more than 3 days before sampling (2.34 [1.71 to 3.2

210 ondary bacteremia or fungemia, ICU length of stay, mortality, and ventilator-free days (VFDs) at 28 d

211 We show that individual's propensity to stay near others, measured by a classic "sociability" as

212 notopic footprint, but the peripheral spread stays non-selective-a surprising finding given a number

213 ry outcomes except for medical ICU length of stay (nurse practitioner-resident-staffed 7.9 +/- 7.5 d

214 on duration of ventilation and length of ICU stay observed in our study.

215 African American odds ratio 3.08, length of stay odds ratio 1.11; and hernia recurrence: porcine cad

216 ne cadaveric mesh odds ratio 2.82, length of stay odds ratio 1.11; complications: drinker odds ratio

217 ess likely to experience prolonged length of stay (odds ratio [OR], 0.50; 95% CI, 0.26-0.97; P = .04)

218 95% CI, 0.87-2.28; p = 0.164), ICU length of stay (odds ratio, 0.90; 95% CI, 0.63-1.30; p = 0.585), o

219 diac surgery who had a planned postoperative stay of >/=24 hours and were considered at increased car

220 29 years, and 33 995 (70.0%) had a length of stay of 30 days or less.

221 pediatric intensive care unit with length of stay of 4 hours or more were evaluated (4560 patient vis

222 A hospital stay of less than 48 hours for routine supportive care w

223 Hospital stays of all donors were 6 days and median sick leave wa

224 However, patients staying on long-term HAART still develop various HIV-ass

225 ss narcotic use, without increased length of stay or complications.

226 hood of a doctor visit or overnight hospital stay or health status as reported by the respondent.

227 ant differences in ICU or hospital length of stay or mortality.

228 oth surgeries, including prolonged length of stay (OR, 1.37; 95% CI, 1.11-1.70) following OAR as well

229 in graft or patient survival, postoperative stay, or morbidity of recipients with grade 1 or 2 throm

230 length-of-stay, infection-related length-of-stay, or readmission were observed between the groups.

231 Participants stayed overnight after the alcohol administration, and d

232 hospital stay (P = 0.013), and 65% less ICU stay (P < 0.001).

233 not NPA) correlated with length of hospital stay (P = .04) and requirement for mechanical ventilatio

234 complications (P < 0.001), 25% less hospital stay (P = 0.013), and 65% less ICU stay (P < 0.001).

235 ry disease (p = 0.83), or hospital length of stay (p = 0.12).

236 .0250), and 1-day shorter length of hospital stay (p=0.0091).

237 time to discharge alive in high-risk, longer stay patients but not significantly so in nutritionally

238 ICU readmissions, prolonged ICU and hospital stay, persistent cognitive problems, and higher mortalit

239 : 14.3%; P = 0.032), and prolonged length of stay (pLOS) (USMG: 22.7%, IMG: 22.8%; P = 0.352) were cl

240 s with risk-adjusted postoperative length of stay (pLOS).

241 s for achieving TO were a prolonged hospital stay, postoperative complications, and readmissions.

242 0.657-0.896, P = 0.001); hospital length-of-stay, postoperative morbidity, and postoperative mortali

243 e development or validation of ICU length of stay prediction models.

244 ATA EXTRACTION: Clinicians use ICU length of stay predictions for planning ICU capacity, identifying

245 a, congestive heart failure (CHF), length of stay, preterm labor, anemia complicating pregnancy, plac

246 ivated black phosphorus thin film flakes can stay pristine for a period of 19 days when left in a dar

247 was associated with posttransplant hospital stay (r = 0.34, P = 0.04), but not with delisting/mortal

248 +/- 0.73; P = 0.009) and hospital length of stay (r = 0.583, P = 0.003).

249 via a significant correlation with length of stay (r = 0.586, P < .0001).

250 spite being associated with longer length of stay (relative risk, 1.17; 95% CI, 1.09-1.26; P < .001).

251 Median hospital length of stay remained unchanged at 3.0 (interquartile range 2.0-

252 located in a hospital, had more than 50 long-stay residents, had less than 20% of the population aged

253 e load of exposure to carriers and length of stay seemed to have an additive effect on the risk of co

254 ration depth; in waterlogged lowlands, roots stay shallow, avoiding oxygen stress below the water tab

255 The mean symptom score stayed similar across time points in the control group,

256 Most VTEs occur after hospital stay; still a few patients receive extended pharmacoprop

257 of treatment and shorter length of hospital stay than treatment with oral morphine, with similar rat

258 US Court of Appeals for the Sixth Circuit to stay the rule, and the subsequently elected administrati

259 he confidence in interpretation increased or stayed the same, with an average improvement of 28% +/-

260 nical end points were the length of hospital stay, the percentage of infants who required supplementa

261 s grow into HSPG-deficient areas but fail to stay there.

262 analysis using data from patients' hospital stays to retrospectively identify patient subgroups from

263 The gonads of the remaining fish stayed undifferentiated until six months after fertiliza

264 e correlated with changes in index length of stay, use of observation status, or discharge to a skill

265 between these groups and patients' length of stay using multivariable Cox proportional hazards regres

266 odel to further refine identification of ICU stays using administrative data.

267 The median observed cost of a unit stay was $9,619 (mean = $16,353).

268 Median (IQR) ICU and hospital stay was 0 (0-2) and 12 (9-18) days, respectively.

269 The mean (SD) length of stay was 11 (5) days, and the all-cause 30-day readmissi

270 Median length of stay was 4 days (range 2 to 6 days).

271 bleeding in 2 patients, and median length of stay was 4 days [3-5.5 days].

272 The mean length of hospital stay was 6.4+/-7.3 days with a mean+/-SD cost of hospita

273 Median intensive care unit stay was 7 days (interquartile range, 4-15 days) versus

274 Median length of stay was 7 days (range 4 to 50).

275 e of digestive tract colonization during ICU stay was 7% (95% CI, 5-10) and it varies from 3% (95% CI

276 Post-transplant length of stay was also similar between the 2 groups.

277 Median ICU length of stay was between 2 and 6.9 days.

278 ICU stay was comparable between the groups.

279 PICU length of stay was increased in children with delirium (adjusted r

280 rval, CI 1.23-3.73; P = 0.007) and length of stay was no different (+1% for nonoverlapping cases; 95%

281 ersus 21%, P < 0.01), and the mean length of stay was reduced, although the difference was not statis

282 Median hospital stay was shorter after MIE (14 vs 13 days, P = 0.001).

283 Overall, hospital stay was shorter after MIG compared with OG (8 vs 10 day

284 Mean length of stay was shorter in the POCT group (5.7 days [SD 6.3]) t

285 Length of stay was significantly reduced in the negative pressure

286 Median hospital length of stay was significantly shorter in alemtuzumab group (4 d

287 iated with reduced duration of ICU length of stay (weighted mean difference, -1.16 d [95% CI, -1.97 t

288 Clinical failure and length of stay were also analyzed.

289 lity, complications, and prolonged length of stay were compared between IMG and USMG surgeon status u

290 ng, no differences in mortality or length of stay were observed.

291 Adjusted 1-year mortality and length of stay were significantly higher in patients with VRE BSI.

292 nous ammonia at day 5 and length of hospital stay were significantly lower in the LOLA group.

293 skilled nursing, and rehabilitation facility stays) were collected via a retrospective structured int

294 pronounced for patients with an extended ICU stay who were receiving mechanical ventilation.

295 A total of 1,042,710 adult patient stays with ICU length of stay more than 24 hours, of whi

296 s, poor hand hygiene, and overnight hospital stays with respiratory complaints.

297 All of our experimental data stay within these physical boundaries over six orders of

298 0.00001) and shorter postoperative hospital stay (WMD: -2.36 [-3.06 to -1.66] d, p < 0.00001) were o

299 s that by using this strategy, the length-of-stay would be reduced by 10%.

300 es of the program (e.g., decreased length of stay) would have a significant positive economic impact.